Available IPD datapackage for study 'A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy'

The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared with sitagliptin and placebo in patients with type 2 diabetes mellitus who are receiving treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate glycemic (blood sugar) control.

本研究旨在评估卡格列净（canagliflozin）相较于西格列汀（sitagliptin）及安慰剂，在接受二甲双胍单药治疗（即单一药物治疗）且血糖控制不佳的2型糖尿病患者中的疗效与安全性。